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ABSTRACT

A recombinant RNA virus is provided allowing encapsidation of genetically engineered viral sequences in heterologo,s7
rod-shaped coat, protein capsids. since
icosahedral viruses are limited in the amount of RNA they
can carry, and rod-shaped viruses are expansible, this invention allows the size of recombinant virus RNA components
to be increased (or decreased). Methods of making and using
such recombinant viruses are also provided, specifically
with respect to the transfection of plants to bring about
genotypic and phenotypic changes.

11 Claims, 1Drawing Sheet
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Plant Virus Infections and Comparative Diagnosis, E.
Kurstak (ed.), at 541-564; P. J. G. Butler (1984) "The
Chrrent Picture of the Structure and Assembly of Tobacco
This application is a continuation of application Ser. No.
081158,082, filed N ~ 23,~ 1993,
.
now ~ b ~ dwhich
~ ~is ~ Mosaic
d , Virus," J. Gen. Virol. 65253-279; D. L. Beck, et al.
a continuation of application Ser. NO. 071978,313, filed NOV. 5 (19851, "Synthesis of Full-length cDNA Clones of TMV,"
P h ~ t o ~ a t h o l o7.511334
g~,
(Abstract); and W. 0 . Dawson, et
17, 1992, now Abandoned, which is a continuation of
application Ser. No. 071518,242, filed May 4, 1990, now
al (Iga6)
of the
Genome of
Tobacco Mosaic Virus and Production of Infectious TranAbandoned, which is a continuation of application Ser. No.
scripts," Proc. Natl. Acad. Sci. U.S.A. 83:1832-1836.
071012,253, filcd Feb. 9, 1987, now Abandoned.
The coat protein of such rod-shaped virions is encoded by
lo
an RNA gene. An assembly origin sequence is also necesFIELD OF INVENTION
sary to initiate packaging. A cDNA clone containing the
assembly origin of TMV Cowpea Strain (Cc) and coat
This invention relates to the use of RNA plant viruses for
protein gene has been isolated by T. Meshi, et al. (1981)
genetic engineering to transform plant cells and systemically
~~Nucleotide
Sequence of a Cloned cDNA Copy of TMV
infect plants, and in particular relates to packaging viral 15 (Cowpea Strain) RNA, Including the Assembly Origin, the
sequences in heterologous coat proteins.
Coat Protein Cistron, and the 3' Non-Coding Region," Mol.
Gen. Genet. 184:2&25. In this particular %UVstrain, the
assembly origin sequences are within the coat protein gene;
BACKGROUND OF THE INVENTION
however, in other strains, the assembly origin and coat
It has been recognized that RNA viruses am useful in the 20 protein genes are separate.
genetic engineering of plants, particularly (*) strand meshe coat proteins of rod-shaped virions are assembled in
senger sense RNA viruses. See, e.g., U.S. Patent application
a helical array,
encapsidate the RNA rod-shaped viral
Scr. No. 580,445 and the continuation-in-part application
particle with RNA wound helically within the interior of the
thereof filed simultaneously herewith, and Ser. No. 709,181,
extendable particle. Thus, in order to increase the size range
incorporated herein by reference.
25 of genetically engineered RNA vital sequences, it is an
object of this invention to provide a recombinant RNA
A problem with prior methods involving the use of RNA
sequence encapsidated in a rod-shaped coat.
viruses for genetic engineering of plants, however, has been
the fact that many plant viruses providing suitable sites for
In general, it would be desirable to package viral
sequences in any heterologous coat protein capsid, for
the insertion of RNA copies of foreign genes are encapsidated in their naturally infective state in spherical or icosa- 30 example when the desired host has established immunities
against the natural coat protein of the viral sequence with
hedral capsids which impose geometric constraints on the
amount of genetic material which can be carried by these
which infection is desired. However, prior to this invention,
no hybrid viruses combining functions (e.g., host specificity,
viruses.
infectivity, and the like) derived from more than one RNA
Examples of such useful viruses are the tripartite
of Tricomaviridae, such as brome mosaic virus (BMV), and 35 virus had been ~onstructed.
A viable recombinant was constructed at the cDNA level
cowpea chlorotic mottle virus (CCMV), which are packaged
between poliovirus types 1 and 3 which are 70% homoloin icosahedral capsids. The BMV RNAl segment has been
cxtcnsively studied as a carrier for heterologous RNA;
gous in RNA sequence (G. Stanway et al. (1986), "Conhowever, observation of the structure of functional elements
struction of poliovirus intertypic recombinants by use of
of this RNA segment indicate that the 3.2-3.3 kb size of the 40 cDNA," J. Virol. 57: 1187. This recombinant carried the 0.74
kb 5' untranslated sequence and first 11 polyprotein codons
natural BMV RNAl is probably near the maximum size
from type 3, with the remainder of the sequence from type
which can be carried by the icosahedral BMV coat.
BMV RNA3 is around 2.1 kb in size, so only around 1 kb
1. A second recombinant reported involved insertion of a
at most of foreign sequence could be added to a packagable 45 portion of the VP1 capsid protein gene from type 3 into a
type 1 Context, but this was n0n-viable, indicating problems
RNA3 derivative without deletion of a
of the natural
in combining non-homologous functional regions.
BMV RNA3 sequence. Although in the case of BMV RNA3,
which has been extensively studied, identification of
An additional example of recombination between diversequences which are not required in cis for replication and
gent Picomavirus genomes was the construction of a recomgene expression opens the possibility of constructing vari- 50 bination between poliovirus type 1 and coxsackie B3 virus
ants with such deletions, it is highly desirable for increased
(B. L. Sernler et al. (1986), "A chimeric plasmid from cDNA
freedom and flexibility in making more sophisticated virus
clones of poliovirus and coxsackie virus that is temperaturederivatives to be able to add heterologous RNA sequences
sensitive," Proc. Natl. Acad. Sci. USA 83:1777). In this ease
without being required to delete an equal amount of the
a 0.4 kb segment of the coxsackie B3 5' noncoding region
original viral RNA. The possibility also exists for BMV and 55 was inserted in a poliovirus context, replacing a segment
some other isometric viruses that lower as well as upper
with which it had 70% homology. The resulting recombinant
RNA size limits exist for viral RNA packaging (Ahlquist et
virus was viable but showed a temperature-sensitive replial. (1984) J. Mol. Biol. 172:369-383).
cation phenotype.
It would thus be desirable to encapsidate recombinant
In none of these reported attempts to produce recombinant
RNA viral sequences into a coat protein able to freely 60 viruses was a viable hybrid virus produced in which a
substitute segment had less than 70% homology with the
package pieces of RNA without upper or lower size constraints.
segment it replaced, and in no case were separate functions
from two or more different viruses successfully recombined.
In contrast to the icosahedral viruses, a large class of plant
Nor has the artificial construction of a hybrid RNA plant
viruses have elongated virions with the shape of rigid or
flexuous reds. The tobacco mosaic virus is an example 65 virus from two distinct viral types been reported.
which has been extensively studied. See, e.g., M. H. V. Van
Unencapsidated derivatives of rod-shaped viruses have
been recently used as vectors to carry a foreign gene in
Regenmortel (1981) "Tobamoviruses," in Handbook of
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recombinant RNA (Takamatsu, N. et al., "TMV-RNA mediated foreign gene expression in tobacco plants," In press),
and recombinant RNA sequences have been encapsidated in
a rod-shaped coat in vitro (Sleat, D. E. et al., "Packaging of
Recombinant RNA Molecules into Pscudovirus Particles
Directed by the Origin-of-Assembly Scquence from
Tobacco Mosaic Virus RNA," In press). However, the in
viva packaging of a recombinant viral RNA in a capsid
foreign to the infective viral sequences has not been previously reported.

derived from or corresponding to reverse-transcribed viral or
transposon RNA, viroids and virus satellites.
Such viral sequences must as a minimum have the functions of replicability in the host and ability to infect the host.
Determinants of such functions may be required in cis or in
other cases may be suppliable in trans. An example of a
replication requirement satisfiable in trans is the need for the
presence of the proteins encoded by BMV RNA's 1 and 2 in
order to allow BMV RNA3 to replicate in a host. 1n contrast,
certain replication signals must be present in cis (i.e. directly
linked to RNA3 derivatives) to allow replication of RNA3
derivatives by the machinery induced in the infected cell by
RNA's 1 and 2.
It is also desirable that such original viral sequences have
suitable sites for the addition of foreign or heterologous
genes. The terms ''foreign" and "heterologous" in reference
to genes and sequences mean genes or sequences not
encoded in the original virus in nature. Such foreign genes
or sequences may be inserted in any location not giving rise
to interference with the necessary functions of the original
viral sequences, i.e., the ability to replicate and infect a host.
In reference to expression in a host, a "heterologous" gene
is one which is not naturally present in the location in the
host in which it has been placed.
Similarly, it is desirable that the placement of the heterologous coat protein genes and assembly origins not interfere with such necessary functions of the original viral
sequences.
Coat protein sequences from flexible or rigid rod-shaped
RNA viruses are especially useful in this invention, in
combination with an assembly origin capable of regulating
the coat protein sequences. Generally, as is recognized in the
art, assembly origins are specific to their coat protein genes,
so it is preferred that the coat protein genes rand assembly
origins are derived from the same organism. Coat protein
genes containing their assembly origins within the gene, e.g.
TMV Cowpea (Cc) strain genes, are particularly preferred.
~ h foreign
,
RNA sequences
to the original viral
RNA may be or encode functional R N A ' ~ ,and the host
organism may be transfected and transformed genotypically
or phenotypically. A functional FWA is one which provides
any function which is appropriate and known to be provided
by an RNA segment. Such functions include, but are not
limited to, coding functions in which the RNA acts as a
messenger RNA encoding a sequence which, translated by
the host cell, results in synthesis of a peptide or protein
having useful or desired properties. Such proteins are termed
"functional proteins" herein. The RNA segment may also be
structural, as for example in ribosomal RNA; it may be
regulatory, as for example with small nuclear RNA's or
anti-sense RNA, or it may be catalytic. Anti-sense RNA is
useful to inhibit the function of complementary RNA in the
target cell.
As will be appreciated by those skilled in the art, if the
inserted RNA sequence is in the form of messenger-sense
RNA comprising genes to be directly translated by the
transformed cell, the genes must be free of intervening,
non-translated sequences, such as introns. On the other
hand, inserted genes need not be naturally occurring genes,
but may be modified, composites of more than one coding
Segments, or encode more than one protein. The RNA may
also be modified by combining insertions and deletions in
order to control the total length or other properties of the
modified RNA molecule.
The inserted foreign RNA sequences may be non-viral or
viral in origin, and may correspond either to RNA or DNA

5
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SUMMARY OF THE INVENTION
RNA viruses make useful vectors for genetic engineering
of plants and other higher organisms to confer useful traits
such as herbicide, disease and pest resistance, however
exiting systems are not as flexible as is desired. Encapsidation of an RNA viral sequence appears to be required for its
significant and reliable spread through the host system.
Uncoated RNA viruses, for example, can infect single cells
and protoplasts, and in the case of some single component
FWA viruses, can spread erratically to sites distant from the
original inoculation site. However, efficient transmission
throughout the plant from a single site of infection or
transfection, particularly for the many multicomponent plant
RNA viruses, requires encapsidation in a viral coat. This
invention provides methods for creating hybrid viruses in
which infective viral sequences are packaged in heterologous coat protein capsids. Encapsidated hybrid virions are
also provided, as well as hybrid viral RNA sequences
capable of encapsidation in vitro or in vivo.
As used herein, the term "hybrid RNA virus" refers to
recombinant viruses in which functional sequences from two
or more different viruses are combined to form a viable
organism. Specifically, the hybrid RNA viruses of this
invention are RNA sequences comprising infectious viral
sequences derived from one RNA virus, and an origin of
assembly and coat protein gene derived from another virus
(or other viruses). The term "hybrid RNA virion" refers to
the encapsidated form of such viruses.
Many useful RNA viruses are encapsidated in icosahedral
coats which limits thc size of genes that can be added. A
method of encapsidating RNA vital sequences in rod-shaped
coat protein capsids is therefore provided. These coat protein
capsids are expansible to accommodate large-sized RNA
fragments up to at least the 6.4 kb size of the tobacco mosaic
virus. RNA fragments as large as desired may be encapsidated in rod-shaped particles so long as the particles are not
so large as to be substantially broken by normal physical
manipulations.
A recombinant viral RNA sequence is provided in which
original viral sequences from a virus normally encapsidated
in one type of coat protein are encapsidated in a different
type. Preferably an infectious virus normally encapsidated in
an icosahedral capsid or otherwise not normally encapsidated in a rod-shaped capsid are combined with genes and
assembly origins for the production of a rod-shaped capsid,
thus enabling encapsidation of the original viral sequences
in a rod-shaped capsid. The original viral sequences preferably are modified to contain desirable foreign genes.
An original viral RNA sequence suitable for combining
with heterologous coat protein genes and assembly origins is
a sequence derived from or corresponding to that of an RNA
virus. Examples of such viruses are plus strand viruses such
as BMV, Tricornaviridae in general, and many others, as
known to the art. Further useful virus sequences are those
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in nature. They may be prokaryotic or eukaryotic in origin,
be systemically infected, but is preferably systemically
so long as they are in a form which can be directly translated
infected.
by the translation machinery of the recipient cell or other~
~ for initiating
~
hinfection
~ of thed host organism
~
are
wise recognized and utilized for their functional, structural
well known to the art, and any suitable method may be used,
or regulatory functions.
5 A preferred method for the infection of plants is to contact
As discussod above, "expression" of the foreign RNA
the wounded plant with a solution containing the virus or
sequences may involve the production of functional RNA's
viral W A so as to cause the virus to replicate in, or infect
or functional proteins. This expression may be at any useful
the plant,
level, and as will be appreciated by those skilled in the art,
suitable regulatory elements may be necessary depending on lo
BRIEF DESCRIPTION OF THE FIGURE
the product desired and the host used. Providing such
FIG. 1 shows a schematic diagram of the viral cDNA
regulatory elements is a matter of ordinary skill in the art.
regi0ns
plasmids P~~~~~
BMV m A 3 9
The natural TMV RNA is about 6.4 kb in length. RodP
~ having
~ the coat
~ protein
S start
~ codon modified from
shaped capsids of this invention, however, may be as long or
coat protein and
as short as required. As the maximum size the icosahedral 1s ATG to AAG, pB3ITMV having the
substituted for the BMV RNA3
procapsid of BMV is believed capable of encapsidating is about
tein, and ~~~~~5
Ihe TMV
protein and
3.2 kb, it can be seen that the use of a rod-shaped coat
assembly origin, showing construction of PB~ITMV.
considerably expands the size range of engineered viral
sequences that can be made competent by encapsidation for
DETAILED DESCIUPTION OF THE
systemic spread in hosts previously accessible only to icosa- 20
PREFERRED EMBODIMENTS
hedrally encapsidated viruses.
As discussed below, insertion of foreign RNA sequences
In a preferred embodiment of this invention, an RNA
is preferably done through reverse transcription of all
segment of an icosahedral virus, preferably a tripartite virus,
sequences involved into corresponding cDNA, or in the case
and more preferably BMV, is packaged in a cylindrical
of foreign sequences originally derived from DNA, original 25 capsid, preferably of TMV, and more preferably of TMV
DNA sequences can be used. Any suitable vector may be
Cowpea strain (Cc) coat protein. Preferably, the packaged
used to provide a basis for carrying out such genetic engisequence is also modified to contain a heterologous gene.
neering, all as will be evident to those skilled in the art.
The genome of BMV is divided among messenger sense
Preferred plasmids are discussed in the Example hereof.
R N A ' ~1 , 2 and 3 of 3.2,2.9 and 2.1 kb respectively, CDNA
Techniques for constructing desired DNA sequences or 30 copies of these W A ' s have been cloned into the universal
combinations of DNA fragments are well known to the art,
transcription vector pPM1. The clones, containing RNA's 1,
using appropriate restriction enzymes, ligation techniques
2 and 3, respectively are designated pBlPM18, pB2PM25
and oligonucleotide-directed alterations available for Conand pB3pM1, In order for cells to be infected with BMV
strutting combinations of fragments containing the desired
m A 3 , the proteins encoded by BMV RNA's 1 and 2 must
f~nctions. Techniques for testing Such C O ~ S ~ ~ U C to~ ~35O ~be
S present. In the preferred embodiment these three BMV
assure their operativeness are also well known and will not
RNA's are separately encapsidated in the rod-shaped virus
be discussed in detail herein.
coat protein.
Similarly, any art-known bacterial host for vectors conIn the preferred embodiment, BMV RNA's 1, 2 and 3
taining the DNA sequences of this invention may be utilized
each contain an appropriate assembly origin, but only the
in conducting the genetic engineering andlor obtaining RNA 40 BMV RNA3 sequence contains an added coat protein
transcripts of the DNA sequences in viva. RNA transcripts
although any of the sequences may be modified to contain
may also be produced in vitro, for example by the methods
additional RNA sequences such as sequences encoding
of U.S. Ser. NO. 580,445 and the ~ ~ n t i n ~ a t i ~ n - i n -applipart
functional protein or functional W A ' s . Methods of modication thereof.
4 j fying DNA sequences to insert heterologous or foreign
Any plant may be infected with an RNA sequence of this
sequences are well known to the art. Generally the viral
invention, as will be evident to those skilled in the art, by
RNA sequence is converted to a full-length cDNA transcript
providing appropriate host specificity and replication funcand cloned into a vector, then modified by inserting a foreign
tions. With appropriate constructions, other eukaryotic
DNA segment in a region able to tolerate such insertion
organisms may also be infected, as may single cells and
without disrupting RNAreplication or disturbing infectivity.
tissue cultures. This invention is not limited to any given
It is necessary that the viral RNAbeing packaged have the
class of host or type of RNA virus. The general utility of
gene for its own coat protein deleted or inactivated so as to
providing a heterologous protective Coat Or encapsidation,
avoid interference with the added coat protein gene. Means
especially one allowing size expansion to a viral sequence,
for inactivating viral coat protein genes are well known to
will be recognized by those skilled in the art as an improve- 55 the art. See, e.g. Ahlquist et al. (198 1) "Complete Nucleotide
Sequence of Brome ~ o s a i cvirus RNA3," J. ~ 0 1 Biol,
.
ment in any process involving the use of viruses which can
be improved by added RNA sequences.
153:23-38. A preferred method for inactivating the gene is
The term "systemic infection" means infection spread
simply by deletion of the gene or substantial portions
through the system of the host organism to involve more
thereof. Other methods include point mutation or insertional
than the cells at the site of original inoculation. The entire 60 inactivation.
host organism need not be infected; single organs or even
In order to ensure translational fidelity of the heterologous
Parts of organs are sufficient, depending on the PuTose of
coat protein gene, it may also be necessary to modify the the
the infection.
translation initiation ATG codon for the original coat protein
The term "transfected" as applied to the host organism
if this is not deleted, and this may be accomplished by means
means incorporation of the viral sequences of this invention 65 known to the art, such as oligonucleotide-directed substituinto the cells of the organism in such a way as to be
tion. If the coat protein sequence to be added has its own
replicated therein. To be transfected, the organism need not
translational start codon, deletion or inactivation of the start
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codon for the original protein is necessary; alternatively,
however, it may be retained and used to initiate translation
of the addcd coat protein sequence, provided that any amino
acid sequcnce changes introduced thereby do not interfere
with RNA packaging and capsid formation.
5
Many RNA viruses producing rod-shaped virion ~aflicles
are known to the art (See, e4.7 Plant Virology (2nd ed.1, R.
E. F. att thews (1981) Academic Press, New York, and "4th
Report of the International Committee on tax om on^ of
Viruses", (1982) Intervirology 17:1-199). Useful coat Pro- lo
tein and origin of assembly sequences may be isolated and
reverse transcribed from such viruses by means known to
the art without undue experimentation. Preferred sequences
preferred are 'Oat protein
are TMV sequences, and
genes incorporating their own assembly origins such as the 15
'Oat
protein gene of TMV Cowpea ('c) strain. 'lasmid
P~~~~~ of
et
contains
Meshi et al.
ing to such sequences, and was obtained
for the work discussed here. The wide availability of this
strain and the fact that the sequences of the coat protein gene 20
and
of
have been published CMeshi
et
supra) makes thc reconstruction of this plasmid andlor said
sequences a matter of ordinary skill in the art.
Through standard cloning techniques, the coat protein
gene and assembly origin sequences of rod-shaped virions 25
are ligatcd into the viral sequences to be packaged, preferably at the site where the original coat protein gene for the
virus was removed, but in any event at a site which does not
interfere with the ability of the virus to replicate and infect 3o
its hosts.
'hnslational expression of the inserted new coat protein
gene may be provided by known means. In the example, the
TMV coat protein gene was inserted immediately downstream of the initiation site for subgenomic BMV RNA4,
leading to BMV-directed synthesis of a subgenomic mRNA 35
for TMV coat protein. The TMV gene is thus said to be
placed downstream of a "subgenomic promoter."
The foreign genes for which expression in the host plant
is desired may be inserted at any convenient location in the 40
genome of the original virus which does not interfere with
the ability of the virus to replicate and infect the host.
Preferably the foreign genes are inserted immediately
upstream from the coat protein and its subgenomic prometer. A COPY of the subgenomic Promoter normally regu- 45
lating Coat protein in the original virus may also be placed
Upstream of such foreign genes to allow for their transitional
expression.
RNA transcripts are prepared, in vivo, such as in bacterial
hosts, or in vitro, all as known to the art, and used to 50
inoculate an appropriate plant host or plant tissue. Thc RNA
can be used in encapsidated form or in solution, since
encapsidation will occur within the host organism.
As will be understood by those skilled in the art, a given
virus may require special conditions for optimal infectivity 55
and replication, including the presence of genes acting in cis
or in trans, all of which should be present when infecting the
plant or plant tissue. For example, for infectivity of BMV
RNA3, the presence of BMV RNAl and 2 is necessary.
Moreover, infection by a virus having the necessary host- 60
specificity genes for a given host can in some circumstances
allow infection of the host by a second virus which does not
normally affect that host, e.g. mixed TMV and BMV viruses
will infect both barley and tobacco even though BMV alone
does not infect tobacco and TMV alone does not infect 65
barley (Hamilton and Nichols (1977) Phytopathology,
67:484-489). It is not necessary that all the required genes

8
be identified and mapped if the entire original virus providing the necessary genes is used.
Suitable genes which may be inserted into the original
viral segment for expression in the host plant include the
CAT (chloramphenicol transferase) gene, pest resistance
genes, e.g. Bacillus thuringiensis insecticidal protein genes,
pathogen resistance, herbicide tolerance or resistance, modified growth habit and new metabolic pathway genes, and
genes for production of commercially useful peptides or
pharmaceuticals in plants or other host organism. In general,
any heterologous gene whose expression product is functional within the plant cell can be inserted into the viral
expression system described herein.
Plants may be transfected both under field and greenhouse
conditions. The modifications can be applied at any time
during the growth cycle, depending on the need for the trait.
For example, resistance to a pest could be conferred only if
the crop were at risk for the pest, and at the time when the
crop was most likely to be affected by the pest. Other traits
can be used to enhance secondary properties, for example to
increase the
content of post-harvest forage. Any
plant variety susceptible to infection by an RNA virus can be
phenotypically transformed. The choice of virus and the
details of modification will be matters of choice depending
on parameters known and understood by those of ordinary
in the ad.
Other uses for cells and organisms phenotypically or
genotypically modified by means of a modified RNA
derived from an RNA virus will be readily apparent to those
skilled in the art, given a wide range of RNA viruses to
modify and a wide range of susceptible host cell types. Other
uses for transfected animal cells, bacterial cells and the like
can be readily envisioned. For example, animal cells susceptible to infection by the alphaviruses, which share
homologous nonstructural proteins and many features of
viral replication with BMV, may be infected in cell culture
with a modified alphavirus carrying a desired gene and
thereby caused to express large quantities of a desired
protein within a short time. The encapsidated RNA viruses
of this invention are especially useful when it is necessary to
subject the virus to harsh conditions, due either to environmental conditions or host defenses, which would inactivate
the uncoated virus.
The method of making and using genetically engineered
is described herein with particular reference to BMV
R N A ' ~ ,but the ordinarily skilled artisan will be able to
apply the principles described, using known techniques, to
other viral RNA's.
EXAMPLE
The following discussion describes the insertion of a
TMV coat protein gene and assembly origin in BMV RNA3,
expression of the inserted gene, and in viva packaging of the
hybrid RN.4 in rod-shaped particles.
Plasmid pB3TP7 contains the full-length cDNA copy of
BMV RNA3 from plasmid pB3PMI fused 3' to a promoter
for bacteriophage 'I7 RNA polymerase, allowing biologically active RNA3 transcripts to be produced in vitro. The
initiating ATG codon of the BMV coat protein in this
plasmid was modified by oligonucleotide-directed substitution (Zoller and Smith (1982) Nucl. Acids. Res.
106487-6500; Kunkel (1985) Proc. Natl. Acad. Sci.
82:488-492) to an AAG codon to generate plasmid pB3RS2.
FIG. 1 shows a schematic representation of the viral cDNA
portions of these plasmids.
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prising a first RNA sequence derived from a first virus and
Plasmid pCc8C5 contains a partial cDNA copy of the
a second RNA sequence from a second virus have a morRNA of the cowpea (Cc) strain of tobacco mosaic virus
phologically-different type of coat protein, said second RNA
(Meshi et al., supra). Using standard methods (Maniatis et
al. (1982) Molecular Cloning, CSH Laboratory), the
sequence comprising an origin of assembly and encoding a
approximately 0.5 kb SalI-XbaI fragment of PB3RS2 inte- 5 coat protein heterologous to said first virus, wherein the coat
protein gene of said first virus is deleted from or inactivated
rior to the BMV coat gene was then replaced by the
approximately 0.6 kb MboII-Xbal fragment of PCc8C5,
in said first RNA sequence and said second RNA sequence
which contains the entire coat protein gene of TMV Cc,
is substituted therefor to produce a hybrid RNA molecule
including sequences believed to represent the encapsidation
capable of expressing the coat protein gene of said second
origin of the RNA (Meshi et al., supra). The SalI and MboII lo virus, and wherein said hybrid molecule is constructed in
vitro from said first virus RNA sequence and said second
restriction fragment ends were both repaired to blunt ends
with T4 DNA polymerase prior to ligation. The resulting
RNA sequence, or wherein said hybrid molecule is
plasmid will be referred to as pB3/TMV.
descended from a nucleic acid molecule constructed in vitro
using recombinant DNA technology.
Transcripts from EcoRI-linearized pB3/TMV, including
2. A molecule of claim 1 which is capable of encapsidathe complete BMV RNA3
TMV sequences contained in 15
tion in viva.
that plasmid were inoculated onto barley protoplasts along
3. A molecule of claim 1 further comprising a sequence
with infectious transcripts of BMV RNAl and RNA2 cDNA
heterologous to said first virus which encodes a functional
clones (French et al. (1986) Science 231:1294-1297.) The
protein.
pB3/TMV RNA's were replicated in such infections and
4. A molec~leof claim 1 wherein Said first virus is an
gave rise to a subgenemic RNA of the size expected for a 20
i
~
~ ~ a l ~ evirus.
dral
mRNA initiated at the normal BMV RNA3 subgenomic
5. A molecule of claim 1 wherein said first virus is a
initiation site and containing all sequences between that
rod-shaped virus.
point and the 3' end of the BMV RNA sequence, including
6 . A molecule of claim 1 having a length greater than
the TMV Cc sequence insertion.
RNA samples were derived from protoplasts inoculated 25 about 3.2 kb.
7. A molecule of claim 1 wherein the origin of assembly
with transcripts of wild type cDNA copies of BMV RNA,s
and
'Oat protein gene are derived from TMV.
1 and 2 and either no additional transcript (-) or transcripts
8.
A molecule of claim 1 wherein said RNA sequence
of either wild type BMV RNA3 cDNA or pB3mV. Fluesaid first virus is BMV IZNA3'
rographs of 3Huridine labelled RNA's separated on a 1%
9.
A
molecule of claim 1 wherein said first virus is a plant
30
(W/V)a g m s e gel after extraction from protoplast
variously inoculated and incubated for 20 hours in light at 24
10. A hybrid RNA molecule capable of infection of and
degrees C. showed the presence of all these RNA's.
replication in a host cell, said hybrid RNA molecule com'ysates of
P
~ infected~
~ an RNA
~ segment
P derived~from a first
~ non-rod-shaped
~
~
prising
with transcripts of BMV RNA1l RNA and pB3mV were 35 virus and an RNA sequence from a second rod-shaped virus,
serologicall~-s~ecific
(K.
said second virus RNA sequence encoding an origin of
S.
and R. H. Brlansky
Phytopathology
assembly and coat protein heterologous to said first virus,
66:815-820) using anti-TMV virion antibody, rod shaped
wherein said second virus RNA sequence is placed in a
particles were consistently visualized in repeated experiregion of the RNA segment of said first virus to produce a
These particles had several features
charac- 40 hybrid RNA molecule, wherein said region is able to tolerate
teristic of normal TMV virion particles, including an
such sequence without disrupting RNA replication of or
approximately 20 nm diameter and a central uranyl acetateinfection by said hybrid RNA molecule, and wherein said
staining
The particles were predominantly around
hybrid molecule is constructed in vitro from said first
110 nm in length, while the longest particles visualized in
RNA segment and said second RNA sequences, or wherein
the same way from protoplasts infected with TMV Cc virion 45 said hybrid molecule is descended from a nucleic acid
RNA were around 310 nm in length.
molecule constructed in vitro using recombinant DNA techAssuming a length of 6.4 kb for TMV RNA (Goelet et al.
nology,
(1982) Proc. Natl. Acad. Sci. 82:488-492), and a constant
11. A hybrid RNA molecule capable of infection of and
ratio of RNA to particle length (Butler, supra), these results
replication in a host cell, said hybrid RNA molecule comimply that the major particle form from pB3tTMV infected 50 prising a BMV RNA3 sequence and an RNA sequence
protoplasts contains an approximately 2.3 kb RNA, and that
comprising an origin of assembly and encoding a coat
the length of the P B ~ RNAis
~ V approximately 2.2 kb. A
protein derived from TMV, wherein the BMV coat protein
Small fraction of shorter particles Was also Seen in the
gene is deleted from or inactivated in said BMV RNA3
P B ~ derived
~ V preparations, and a larger fraction and a
sequence and said TMV RNA sequence is substituted therebnxder length distribution of particles shorter than 310 nm 55 for to produce a hybrid RNA molecule capable of expressing
was also Seen from TMV Cc-infected preparations. Such
the coat protein encoded by said TMV RNA sequence, and
smaller particles may arise frombreakage of larger~articles
wherein said hybrid molecule is constructed in vitro from
said BMV RNA3 sequence and said TMV RNA sequence,
or from encapsidation of subgenomic RNA's.
or wherein said hybrid molecule is descended from a nucleic
The foregoing example is provided by way of illustration
60 acid molecule constructed in vitro using recombinant DNA
and not by way of limitation of the invention.
We claim:
technology.
1. A hybrid RNA molecule capable of infection of and
* * * * *
replication in a host cell, said hybrid RNA molecule com-

~

